• ATM Kinase Inhibition and Metabolic Targeting in HGSOC Cells

  2026-05-09

  This study reveals that ATM kinase activity is elevated in high grade serous ovarian cancer (HGSOC) and that its inhibition synergizes with the PPARα agonist fenofibrate to induce senescence in cancer cells. These findings highlight a promising metabolic combinatorial strategy for HGSOC cases resistant to standard DNA repair-targeted therapies.

• Distinct Apoptotic Pathways in BMECs Induced by Candida krus

  2026-05-08

  This study by Miao et al. provides the first detailed mechanistic comparison of how yeast and hypha phases of Candida krusei trigger apoptosis in bovine mammary epithelial cells (BMECs) through distinct signaling routes. These insights have direct implications for understanding fungal mastitis pathogenesis and identifying phase-specific molecular targets for apoptosis inhibition.

• Translating Dual-Fluorescence mRNA into Next-Gen Delivery In

  2026-05-08

  This thought-leadership article explores how EZ Cap™ Cy5 EGFP mRNA (5-moUTP) advances the field of mRNA delivery and translation efficiency assays, drawing on mechanistic insights, peer-reviewed breakthroughs, and real-world translational guidance for researchers. It contextualizes recent innovations in immunoevasive chemistry and dual-labeling, situating APExBIO’s reagent as a pivotal tool for quantitatively optimizing gene function studies and nanoparticle development.

• EphA2 as a Synthetic Lethal Target in MYC-Driven TNBC

  2026-05-07

  This study introduces a chemogenetic screen that identifies EphA2 inhibition as a synthetic lethal vulnerability in MYC-driven triple-negative breast cancer (TNBC). The findings establish EphA2 as a promising therapeutic target and detail a robust screening platform, providing new research directions for MYC-driven malignancies.

• Bradykinin B2 Receptors Regulate Ileal Peristalsis in Guinea

  2026-05-07

  This study delivers the first direct evidence that bradykinin inhibits the peristaltic reflex in the guinea pig ileum via B2 receptor activation. The findings clarify the receptor-specific regulation of intestinal motility and have implications for the selection and interpretation of ACE inhibitor models in hypertension and gastrointestinal research.

• Disulfiram: Synthetic Lethality and Proteasome Inhibition in

  2026-05-06

  Explore how Disulfiram, a dopamine β-hydroxylase inhibitor, enables synthetic lethality strategies in APC-deficient cancer models through proteasome inhibition and ROS pathway activation. This article delivers mechanistic insights and practical assay guidance for advanced cancer research.

• NU6300 Inhibits Gasdermin D-Mediated Pyroptosis via Cysteine

  2026-05-06

  The reference study identifies NU6300 as a covalent inhibitor of gasdermin D (GSDMD), targeting cysteine-191 to block GSDMD cleavage and palmitoylation, thereby suppressing pyroptotic cell death. These findings advance the understanding of inflammasome signaling modulation and provide a new chemical probe for dissecting pyroptosis and inflammation-related pathologies.

• HyperScribe T7 High Yield Cy5 RNA Labeling Kit: Workflow & O

  2026-05-05

  The HyperScribe T7 High Yield Cy5 RNA Labeling Kit from APExBIO streamlines high-yield, customizable fluorescent RNA probe synthesis for sensitive in situ and Northern blot applications. This guide unpacks experimental workflows, actionable optimization strategies, and troubleshooting insights to maximize labeling efficiency and reproducibility in advanced RNA research.

• IWP-L6: High-Precision Porcupine Inhibitor for Wnt Pathway C

  2026-05-05

  IWP-L6 delivers unmatched sub-nanomolar Porcupine inhibition, empowering researchers to dissect the Wnt signaling pathway with exceptional specificity. From zebrafish regeneration models to ex vivo organ culture, this APExBIO tool redefines reproducibility and sensitivity in Wnt pathway research.

• Unidirectional Sarcomere Protein Turnover in Cardiomyocytes

  2026-05-04

  This study overturns the classic 'protein pool' model by demonstrating that sarcomere maintenance in cardiomyocytes follows a unidirectional replacement mechanism, where only newly synthesized proteins incorporate into the contractile apparatus as older ones are degraded. The findings refine our understanding of cardiac muscle homeostasis, with implications for protein turnover research and proteasome inhibitor assay design.

• UTP Solution (100 mM): Powering Precision in RNA and Metabol

  2026-05-04

  Explore how high-purity UTP Solution (100 mM) from APExBIO accelerates cutting-edge RNA synthesis and metabolic pathway studies. This thought-leadership article integrates mechanistic detail with actionable protocol guidance, drawing on recent advances in epigenetic regulation and translational research. The piece not only contextualizes UTP as a cornerstone nucleotide for in vitro transcription and galactose metabolism, but also charts a path for researchers to leverage robust nucleotide substrates to interrogate complex gene expression systems, such as the monogenic olfactory receptor selection illuminated by TRIM66.

• 5-Methyl-CTP: Elevating mRNA Vaccine Design and Translation

  2026-05-03

  This thought-leadership article explores how 5-Methyl-CTP, a 5-methyl modified cytidine triphosphate, is reshaping mRNA vaccine and therapeutic development by providing mechanistic stability and translational advantages. Drawing on both mechanistic insight and recent translational milestones—including robust mRNA vaccine protection in dairy cows against H5N1—this article offers actionable, evidence-based strategies for researchers optimizing in vitro transcription, gene expression studies, and mRNA drug development workflows. By synthesizing recent literature and strategic guidance, it demonstrates APExBIO’s leadership and expands the conversation beyond conventional product pages, arming translational scientists with deeper mechanistic understanding and practical implementation guidance.

• 5-Aminolevulinic acid HCl in Heme Biosynthesis Assays

  2026-05-02

  Uncover how 5-Aminolevulinic acid HCl transforms heme pathway and immune evasion research with robust solubility and precision. APExBIO’s high-purity reagent empowers reliable pathogen virulence assays and cancer imaging workflows.

• Pharmacokinetic/Pharmacodynamic Profiling of Tiamulin in Myc

  2026-05-02

  This study delivers the first detailed in vivo PK/PD characterization of Tiamulin (Thiamutilin) against Mycoplasma gallisepticum in poultry. By linking optimal AUC24h/MIC ratios with significant bacterial reduction, the research informs evidence-based dosing regimens and highlights the antibiotic’s role in controlling respiratory mycoplasmosis.

• Angiotensin 1/2 (5-7): Benchmarks for Renin-Angiotensin Rese

  2026-05-01

  Angiotensin 1/2 (5-7) is a high-purity peptide hormone essential for renin-angiotensin system research and blood pressure regulation. Recent studies confirm its robust vasoconstrictor activity and its role in enhancing SARS-CoV-2 spike protein–host receptor interactions. This article provides atomic evidence, protocol parameters, and cross-domain insights for advanced cardiovascular and viral pathogenesis workflows.

16218 records 1/1082 page Next 12345 下5页 Last page